Produkty w koszyku (0)
  • Twój koszyk jest pusty

 Wybrane badania opublikowane w czasopismach międzynarodowych

  1. Iorio E., Bianchi L.,  Storti A. CELLFOOD (Deutrosulfazyme): a powerful antioxidant, Italy, 2007
  2. Coyle M. Efficacy assessment of CELLFOOD by means of d-ROMs test, NuLife Sciences Company, Massachusetts. USA. 2004
  3. Van Heerden J. Study on the effects of CELLFOOD on elite athletes, Univerity of Pretoria, Sport Institute (South Africa), 2001
  4. Fairhurst D. Report of an Investigation into the Colloidal Nature of CELLFOOD
  5. Milic´, R., Djordjevic´, S., 2009. Cycling performance and Cellfood. In: Loland, S., Bø, K., Fasting, K., Hallén, J., Ommundsen, Y., Roberts, G., Tsolakidis, E. (Eds.), Book ofAbstracts of the 14th Annual Congress of the European College of Sport Science. Gamlebyen Grafiske A.S., Oslo, p. 230.
  6. O’Toole A., Jackie P, Cellfood Concentrate and patients with asthma, UK.
  7. Catalani S., Carbonaro V., Palma F., Arshakyan M., Galati R., Nuvoli B., Battistelli S., Canestrari F., Benedetti S. Metabolism modifications and apoptosis induction after Cellfood™ administration to leukemia cell lines. J Exp Clin Cancer Res. 2013 Sep 9;32(1):63. doi: 10.1 186/1756-9966-32-63.
  8. Benedetti S, Catalani S, Palma F, Canestrari F. The antioxidant protection of CELLFOOD against oxidative damage in vitro. Food Chem Toxicol. 2011 Sep;49(9):2292-8. doi: 10.1016/j.fct.201 1.06.029. Epub 2011 Jun 14.
  9. Nuvoli B., Santoro R., Catalani S., Battistelli S., Benedetti S., Canestrari F., Galati R. CELLFOOD™ induces apoptosis in human mesothelioma and colorectal cancer cells by modulating p53, c-myc and pAkt signaling pathways. J Exp Clin Cancer Res. 2014 Mar 5;33:24. doi: 10.1 186/1756-9966-33-24.
  10. Nieddu M.E., Menza L., Baldi F., Frediani B., Marcolongo R. Efficacy of Cellfood's therapy (deutrosulfazyme) in fibromyalgia. Reumatismo. 2007 Oct-Dec;59(4):316-21. Italian.
  11. Fulgenzi A., De Giuseppe R., Bamonti F., Ferrero M. E. Improvement of oxidative and metabolic parameters by Cellfood™ administration in patients affected by neurodegenerative diseases on chelation treatment. Department of Biomedical Sciences for Health, University of the Study of Milan, Milan, Italy Department of Biomedical, Surgical and Dental Sciences University of the Study of Milan, Hematology-Oncology and BMT Unit, IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy


Raporty z badań in vitro oraz in vivo opracowane przez producenta

  1. Badanie uwalniania tlenu
  2. Badanie skuteczności zwalczania drobnoustrojów
  3. Badania na określenie potencjału zeta
  4. Badanie na określenie napięcia powierzchniowego
  5. Badanie na określenie ostrej toksyczności przy przyjmowaniu doustnym (metoda LD50)
  6. Test BAP (badanie na określenie biologicznego potencjału przeciwutleniającego)